Balaxi Pharmaceuticals
20.02
-0.29(-1.43%)
Market Cap₹110.53 Cr
PE Ratio11.88
IndustryHealthcare
Company Performance:
1D-1.43%
1M-17.14%
6M-57.19%
1Y-64.60%
5Y-82.25%
View Company Insightsright
Latest news about Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Soars 22% Amid Major Stake Transfers Mar 05, 2025
Balaxi Pharmaceuticals' stock price surged over 22% in two days following significant ownership changes. Ebisu Global Opportunities Fund and Unico Global Opportunities Fund each acquired approximately 8% stake at ₹53 per share. Simultaneously, MGC Fund Limited and Elala India Opportunities Fund divested their 8% stakes at the same price. The consistent transaction price suggests a mutually agreed valuation. The market responded positively to these bulk deals, reflecting increased investor interest in the company's future prospects.
no imag found